Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)

NCT03782636 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Type1 Diabetes

Interventions

DRUG: Aldesleukin
OTHER: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]